Seletracetam
From Self-sufficiency
| 150px | |
| 150px | |
| Systematic (IUPAC) name | |
|---|---|
|
(2S)-2-[(4R)-4-(2,2-difluoroethenyl) -2-oxo-pyrrolidin-1-yl]butanamide | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | >90% |
| Biological half-life | 8h |
| Identifiers | |
| CAS Number | 357336-74-4 |
| ATC code | none |
| PubChem | CID 9942725 |
| Chemical data | |
| Formula | C10H14F2N2O |
| Molar mass | 232.227[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Seletracetam is a drug of the racetam family. It is currently being developed by UCB Pharmaceuticals as an anticonvulsant drug. While similar in structure to so-called nootropic drugs, it is not expected to have cognitive enhancing properties.
See also
| 35px | This drug article relating to the nervous system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- 2Fix
- Racetams
- Pyrrolidones
- Organofluorides
- Alkenes
- Butyramides
- Nervous system drug stubs
